| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/24/2009 | CA2717922A1 Arylsulfonyl pyrazoline carboxamidine derivatives as 5-ht6 antagonists |
| 09/24/2009 | CA2717419A1 Synergic 5'-methylthioadenosine combinations |
| 09/24/2009 | CA2714662A1 Trisubstituted 1,2,4-triazoles as nicotinic acetylcholine receptor modulators |
| 09/24/2009 | CA2710811A1 N-phenyl-imidazo[1,2-a]pyridine-2-carboxamide compounds, preparation thereof and therapeutic application thereof |
| 09/23/2009 | EP2103613A1 Quinoxaline derivative |
| 09/23/2009 | EP2103607A1 1-phenyl 1-thio-d-glucitol derivative |
| 09/23/2009 | EP2103598A1 Fluorinated cycloalkyl-derived benzoylguanidine, method for producing same, use of same as medicine and medicine containing same |
| 09/23/2009 | EP2103305A1 Therapeutic agent for diabetic neuropathy |
| 09/23/2009 | EP2103304A1 Composition for improving brain function |
| 09/23/2009 | EP2103303A2 Controlled release formulation |
| 09/23/2009 | EP2102209A2 Novel triazabenzo[a]naphtho[2,l,8-cde]azulene derivatives, method for preparing the same and pharmaceutical compositions containing the same |
| 09/23/2009 | EP2102208A1 Novel substituted diaza spiro pyridinone derivatives for use in mch-1 mediated diseases |
| 09/23/2009 | EP2102206A1 Salts of 3-(3-amino-2-(r)-hydroxy-propyl)-1-(4-fluoro-phenyl)-8-(8-methyl-naphthalen-1-ylmethyl)-1,3,8-triaza-spiro[4.5]decan-4-one |
| 09/23/2009 | EP2102204A1 New aminopyrrolo[1,2- a]indole et aminopyridazino[1,6-a]indole derivatives, method for preparing the same and pharmaceutical compositions containing the same |
| 09/23/2009 | EP2102165A2 N-(methyl)-1h-pyrazol-3-amine, n-(methyl)-pyridin-2-amine and n-(methyl)-thiazol-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid-like proteins, like e.g. alzheimer's |
| 09/23/2009 | EP2102153A1 Ampa receptor potentiators |
| 09/23/2009 | EP2101806A2 Treatment of disease or injury of the nervous system using agents that decrease the activity of the melanocortin 4 receptor |
| 09/23/2009 | EP2101776A2 Treatment of anxiety with eszopiclone |
| 09/23/2009 | EP2101770A2 Medicinal delivery system and related methods |
| 09/23/2009 | EP2101769A2 Methods for the treatment of alcohol abuse, addiction and dependency |
| 09/23/2009 | EP2101768A2 Use of neuroprotective compounds for obtaining drugs for treating neurodegenerative diseases |
| 09/23/2009 | EP2101766A1 Compositions and methods of using (r)-pramipexole |
| 09/23/2009 | EP2101763A2 Pharmaceutical compositions and their methods of use |
| 09/23/2009 | EP2101762A1 Novel 2 -imidazoles as ligands for trace amine associated receptors (taar) |
| 09/23/2009 | EP2101751A1 Benzamide derivatives as ep4 receptor agonists |
| 09/23/2009 | EP2101748A2 Uses of incensole, incensole acetate and derivatives thereof |
| 09/23/2009 | EP2101746A1 V3 antagonists for the treatment or prevention of chronic pain |
| 09/23/2009 | EP2101744A2 Oral transmucosal nicotine dosage form |
| 09/23/2009 | EP2101730A2 Galenic form for the transmucosal delivery of paracetamol |
| 09/23/2009 | EP2101579A1 Means for improving cognitive functions and memory based on hydrogenated pyrido (4,3-b) indoles (variants), pharmacological means based thereon and method for the use thereof |
| 09/23/2009 | EP1819713B1 Isoxazoline-indole derivatives with an improved antipsychotic and anxiolytic a ivity |
| 09/23/2009 | EP1648893B1 Nicotine addiction reducing heteroaryl fused azapolycyclic compounds |
| 09/23/2009 | EP1482928B1 Mediators of hedgehog signaling pathways,compositions and uses related thereto |
| 09/23/2009 | EP1461038B9 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 09/23/2009 | EP1416966B1 Methods for treating joint inflammation, pain, and loss of mobility |
| 09/23/2009 | EP1377288B1 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase iv and use |
| 09/23/2009 | EP1283682B1 Tryptophan source from plants and uses therefor |
| 09/23/2009 | EP1214944B1 Composition for PERCUTANEOUS ABSORPTION with a compound having a melatonin receptor agonist activity |
| 09/23/2009 | CN101538311A Alpha-amido acyl-ring imide peptoid metalloprotease inhibitor and application thereof |
| 09/23/2009 | CN101538270A 8-alkyl galanthamine salt and preparation method and applications thereof |
| 09/23/2009 | CN101538258A New composition of salvia miltiorrhiza and derivative, preparation method and medicine application thereof |
| 09/23/2009 | CN101538254A Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme |
| 09/23/2009 | CN101538244A 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity |
| 09/23/2009 | CN101538218A Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases |
| 09/23/2009 | CN101538213A Polymouphous substance of bupropion hydrobromic acid and preparation method thereof |
| 09/23/2009 | CN101537158A Chinese medicinal preparation for treating schizophrenia |
| 09/23/2009 | CN101537155A Mongolian preparation for tonifying kidney, invigorating spleen and relieving mental stress and preparation method thereof |
| 09/23/2009 | CN101537151A Pharmaceutical composition having effects of alleviating alcoholism, protecting liver, invigorating stomach and clearing bowels |
| 09/23/2009 | CN101537133A Chinese medicinal preparation for treating paralysis agitans |
| 09/23/2009 | CN101537132A Chinese medicinal preparation for treating epilepsy |
| 09/23/2009 | CN101537131A Rehabilitation capsule for detoxing drug addicts |
| 09/23/2009 | CN101537129A Applications of dendrobium nobile lindl alkaloids in medicines prepared for treating ischemic brain damage and product thereof |
| 09/23/2009 | CN101537128A Applications of dendrobium nobile lindl alkaloids in medicines prepared for treating senile dementia and product thereof |
| 09/23/2009 | CN101537112A Formulation method for treating chicken bronchitis and mental depression |
| 09/23/2009 | CN101537100A Novel use l of Chinese herbal medicines like Chinese yam, poria cocos, hypoglauca yam, cistanche deserticola and eucommia ulmoies for treating poliomyelitis sequela |
| 09/23/2009 | CN101537079A Pharmaceutical composition or health-care product for improving sleeping and delaying senility and preparation method thereof |
| 09/23/2009 | CN101537075A Drug for withdrawal of novel drug addiction and processing method thereof |
| 09/23/2009 | CN101537071A Chinese medicinal preparation for treating hereditary ataxia |
| 09/23/2009 | CN101537070A Chinese medicinal preparation for treating trigeminal neuralgia |
| 09/23/2009 | CN101537069A Chinese medicinal preparation for treating erythromelalgia |
| 09/23/2009 | CN101537053A Novel use of Chinese herbal medicines like papaya, achyranthes and angelica for treating poliomyelitis sequela by utilizing |
| 09/23/2009 | CN101537051A Chinese medicinal preparation for treating sciatica |
| 09/23/2009 | CN101537047A Novel use of Chinese herbal medicines like honeysuckle flower, forsythia, peppermint and scutellaria for treating poliomyelitis sequela |
| 09/23/2009 | CN101537045A Novel use of Chinese herbal medicines like mulberry twigs, angelica and safflower for treating poliomyelitis sequela |
| 09/23/2009 | CN101537043A Novel use of Chinese herbal medicines like raw astragalus, angelica, cassia twig and achyranthes for treating poliomyelitis sequelae |
| 09/23/2009 | CN101537011A Pharmaceutical composition for preventing or treating parkinsonism and preparation method thereof |
| 09/23/2009 | CN101536993A Vitamin D3 microcapsule and preparation method thereof |
| 09/23/2009 | CN101536979A Edaravone lipid microsphere formulation and preparation method |
| 09/23/2009 | CN101536859A Traditional Chinese medicine health-care pillow and preparation method thereof |
| 09/23/2009 | CN101536858A Healthcare pillow for treating insomnia |
| 09/23/2009 | CN101536854A Health-caring process quilt |
| 09/23/2009 | CN100543016C Intermediate compound of 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives |
| 09/23/2009 | CN100542607C Anti-myelin associated glycoprotein (MAG) antibodies |
| 09/23/2009 | CN100542606C Vaccine composition comprising tumour antigen and adjuvant composition |
| 09/23/2009 | CN100542561C Medicament for nourishing heart and relieving mental strain and its preparation method |
| 09/23/2009 | CN100542546C Glossy ganoderma extract and preparation method and use thereof |
| 09/22/2009 | US7592455 potent and selective inhibitors of p38 kinase, especially p38 alpha , p38 beta and p38 beta 2; immune or inflammatory disorders; Ethyl 3-(benzylamino)-6-oxo-7-phenyl-6,7-dihydrothieno[2,3-b]pyridine-2-carboxylate |
| 09/22/2009 | US7592454 Substituted hexahydro-pyridoindole derivatives as serotonin receptor agonists and antagonists |
| 09/22/2009 | US7592450 used to inhibit proliferative conditions, such as cancer and psoriasis, with improved bioavailability and stability |
| 09/22/2009 | US7592360 3-fluoro-piperidines as NMDA/NR2B antagonists |
| 09/22/2009 | US7592350 Polycyclic compounds as potent alpha2-adrenoceptor antagonists |
| 09/22/2009 | US7592347 Piperazine derivates and their use for the treatment of neurological and psychiatric diseases |
| 09/22/2009 | US7592340 Quinoxalines useful as inhibitors of protein kinases |
| 09/22/2009 | US7592339 Substituted oxazolidinones and their use in the field of blood coagulation |
| 09/22/2009 | US7592337 Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5 |
| 09/22/2009 | US7592333 Loxapine analogs and methods of use thereof |
| 09/22/2009 | US7592309 Method of using a peptide having analgesic and antitumor activity from scorpion |
| 09/22/2009 | US7591949 Method for the improvement of transport across adaptable semi-permeable barriers |
| 09/22/2009 | CA2426349C Over-coated chewing gum formulations including tableted center |
| 09/22/2009 | CA2402121C Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals |
| 09/22/2009 | CA2400236C Use of indoloquinoxaline derivatives for preparing a drug for the treatment of multiple sclerosis |
| 09/22/2009 | CA2398274C Adenosine receptor modulators |
| 09/22/2009 | CA2396720C Thiazolyl amide derivatives |
| 09/22/2009 | CA2360894C (1-phenacyl-3-phenyl-3-piperidylethyl) piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same |
| 09/22/2009 | CA2333086C Cocaine receptor binding ligands |
| 09/19/2009 | CA2717166A1 Methods of modulating t cell-dependent immune responses |
| 09/17/2009 | WO2009114740A2 USE OF GABAa RECEPTOR ANTAGONISTS FOR THE TREATMENT OF EXCESSIVE SLEEPINESS AND DISORDERS ASSOCIATED WITH EXCESSIVE SLEEPINESS |
| 09/17/2009 | WO2009114597A1 Apoaequorin-containing compositions and methods of using same |
| 09/17/2009 | WO2009114575A1 Tricyclic spiro pyrimidine derivatives as histamine h4 ligand |
| 09/17/2009 | WO2009114539A2 Neuroprotective integrin-binding peptide and angiopoietin-1 treatments |